Treatment dilemmas in sarcoidosis - a retrospective cohort study

R. Trafford, A. Abelidis, L. S. Liu, M. Babores, S. Iyer (Macclesfield, United Kingdom)

Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Session: Sarcoidosis and other granulomatosis
Session type: Thematic Poster Session
Number: 3797
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Trafford, A. Abelidis, L. S. Liu, M. Babores, S. Iyer (Macclesfield, United Kingdom). Treatment dilemmas in sarcoidosis - a retrospective cohort study. Eur Respir J 2013; 42: Suppl. 57, 3797

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The Minasarc study: A case-control study measuring mineral exposome in sarcoidosis
Source: International Congress 2016 – Human responses to exposure, including physiological and biomarker outcomes
Year: 2016


Lung cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019

Lung cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study in Europe.
Source: Virtual Congress 2021 – The future of idiopathic pulmonary fibrosis
Year: 2021



Diagnosis of cardiac sarcoidosis: A crossectional study in 327 consecutive patients
Source: International Congress 2014 – Sarcoidosis
Year: 2014

Steroid treatment effect in pulmonary sarcoidosis (STEPS study)
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015

PROOF-registry: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting
Source: International Congress 2014 – ILDs 6
Year: 2014


Does the HLA-DRB1-genotype influence the course of disease in Danish sarcoidosis patients?
Source: Annual Congress 2013 –Sarcoidosis
Year: 2013


Pulmonary function tests as predictors of mortality in patients with sarcoidosis
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015

Is pulmonary sarcoidosis more severe in children? A multicentric retrospective study
Source: International Congress 2014 – Sarcoidosis
Year: 2014


Prevalence of cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018

Treatment of IPF with inhaled IFN-gamma; planning for a clinical trial
Source: International Congress 2014 – ILDs 3
Year: 2014


Pulmonary manifestations in rheumatoid arthritis: A hospital based descriptive study
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014


PROOF-registry: A prospective observational registry to describe the disease course and outcomes of IPF patients in a real-world clinical setting- An interim report
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015


Lung ultrasound in children with interstitial lung disease: a pilot study.
Source: Virtual Congress 2020 – Tip the hat to paediatric bronchology
Year: 2020




Clinical study of pediatric interstitial lung diseases in China
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013


Genetic analysis of ethnicity of sarcoidosis patients in the Netherlands
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013

Desquamative interstitial pneumonia in a Danish cohort, treatment response and outcome
Source: International Congress 2014 – ILDs 2
Year: 2014

How many patients require corticosteroid treatment in sarcoidosis? – Preliminary study
Source: International Congress 2014 – Sarcoidosis
Year: 2014

Acute fibrinous and organizing pneumonia: A retrospective study
Source: International Congress 2015 – Interstitial lung diseases I
Year: 2015


Long-term safety of pirfenidone in RECAP, an open-label extension study in patients with idiopathic pulmonary fibrosis, interim results
Source: International Congress 2014 – Clinical trials in IPF
Year: 2014